Rolf Lewensohn Selected Research

Rolf Lewensohn Research Topics

Disease

44	Neoplasms (Cancer) 10/2022 - 01/2002
30	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2022 - 10/2002
15	Lung Neoplasms (Lung Cancer) 01/2019 - 06/2004
13	Carcinoma (Carcinomatosis) 10/2022 - 01/2002
7	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 04/2020 - 10/2002
6	Neoplasm Metastasis (Metastasis) 01/2022 - 11/2011
5	Neutropenia 04/2022 - 12/2015
5	Pleural Effusion (Pleural Effusions) 12/2021 - 07/2009
5	Adenocarcinoma 11/2021 - 02/2010
5	Breast Neoplasms (Breast Cancer) 01/2019 - 05/2003
4	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 06/2022 - 06/2008
4	Drug-Related Side Effects and Adverse Reactions 04/2022 - 01/2016
4	Thrombocytopenia (Thrombopenia) 01/2020 - 12/2015
3	Leukopenia 04/2022 - 01/2020
3	Adenocarcinoma of Lung 10/2018 - 07/2009
3	Glioma (Gliomas) 12/2017 - 03/2005
3	Leukemia 06/2009 - 12/2003
2	Melanoma (Melanoma, Malignant) 01/2022 - 08/2021
2	Brain Neoplasms (Brain Tumor) 02/2018 - 12/2007
2	Tics (Tic) 01/2018 - 08/2014
2	Glioblastoma (Glioblastoma Multiforme) 12/2017 - 04/2009
2	Ovarian Neoplasms (Ovarian Cancer) 09/2016 - 12/2015
2	Multiple Myeloma 06/2013 - 08/2004
2	Mitochondrial Diseases (Mitochondrial Disease) 06/2013 - 01/2002
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 02/2010 - 04/2003
2	Prostatic Neoplasms (Prostate Cancer) 10/2008 - 06/2008
1	Disease Progression 05/2022
1	Lung Diseases (Lung Disease) 10/2018
1	Ataxia Telangiectasia (Louis Bar Syndrome) 01/2018

Drug/Important Bio-Agent (IBA)

13	Proteins (Proteins, Gene)FDA Link 10/2022 - 11/2003
12	Biomarkers (Surrogate Marker)IBA 04/2022 - 06/2008
9	DNA (Deoxyribonucleic Acid)IBA 02/2021 - 04/2003
7	Biological ProductsIBA 01/2019 - 02/2006
6	Gemcitabine FDA Link 04/2022 - 01/2016
6	Pharmaceutical PreparationsIBA 09/2016 - 01/2002
5	Carboplatin (JM8)FDA LinkGeneric 04/2022 - 01/2016
5	Phosphotransferases (Kinase)IBA 01/2019 - 10/2003
5	Melphalan (Alkeran)FDA LinkGeneric 12/2015 - 12/2003
5	CaspasesIBA 06/2013 - 01/2002
4	MicroRNAs (MicroRNA)IBA 05/2022 - 10/2013
4	Tyrosine Kinase InhibitorsIBA 05/2022 - 01/2019
4	PlatinumIBA 04/2020 - 09/2015
4	Small Interfering RNA (siRNA)IBA 01/2018 - 02/2007
4	Cisplatin (Platino)FDA LinkGeneric 01/2018 - 10/2003
4	melflufenIBA 09/2016 - 06/2013
3	lysyl- arginyl- alanyl- lysyl- alanyl- lysyl- threonyl- threonyl- lysyl- lysyl- arginine (PKCS)IBA 02/2021 - 04/2003
3	tyrosine receptor (receptor, tyrosine)IBA 01/2019 - 12/2007
3	Alkylating AgentsIBA 09/2016 - 06/2013
3	Peptide Hydrolases (Proteases)FDA Link 09/2016 - 07/2003
3	ProteomeIBA 02/2010 - 07/2008
3	Etoposide (VP 16)FDA LinkGeneric 08/2004 - 10/2002
2	Gemtuzumab (Mylotarg)FDA Link 06/2022 - 06/2009
2	ErbB Receptors (EGF Receptor)IBA 05/2022 - 01/2019
2	EphrinsIBA 02/2021 - 05/2011
2	Eph Family Receptors (Eph Receptors)IBA 02/2021 - 09/2016
2	Genetic Markers (Genetic Marker)IBA 01/2020 - 01/2020
2	Tumor Biomarkers (Tumor Markers)IBA 01/2019 - 01/2018
2	DNA-Activated Protein KinaseIBA 01/2018 - 08/2004
2	Bleomycin (Blenoxane)FDA LinkGeneric 12/2017 - 08/2007
2	Tamoxifen FDA LinkGeneric 01/2015 - 10/2008
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 12/2014 - 10/2008
2	Insulin-Like PeptidesIBA 08/2014 - 05/2005
2	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 08/2014 - 04/2009
2	ProdrugsIBA 06/2013 - 09/2007
2	EnzymesIBA 06/2013 - 07/2003
2	DipeptidesIBA 06/2013 - 01/2003
2	Peptides (Polypeptides)IBA 07/2009 - 01/2003
2	Insulin (Novolin)FDA Link 04/2009 - 12/2007
2	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 04/2009 - 12/2007
2	L-melphalanyl-p-L-fluorophenylalanine ethyl esterIBA 09/2007 - 01/2003
1	Caspase 2IBA 06/2022
1	osimertinibIBA 05/2022
1	AlkanesIBA 04/2022
1	Immune Checkpoint InhibitorsIBA 11/2021
1	Membrane Proteins (Integral Membrane Proteins)IBA 09/2021
1	Erythropoietin FDA Link 02/2021
1	Circulating Tumor DNAIBA 02/2021
1	P-2 (P 2)IBA 01/2020
1	NucleotidesIBA 01/2020
1	Anaplastic Lymphoma KinaseIBA 01/2019
1	CrizotinibIBA 01/2019
1	lorlatinibIBA 01/2019
1	locked nucleic acidIBA 01/2019
1	ChemokinesIBA 01/2019
1	RNA (Ribonucleic Acid)IBA 10/2018
1	Carrier Proteins (Binding Protein)IBA 01/2018
1	Vorinostat FDA Link 01/2018
1	EuchromatinIBA 01/2018
1	Lysine (L-Lysine)FDA Link 01/2018
1	Histones (Histone)IBA 01/2018
1	Histone Deacetylases (Histone Deacetylase)IBA 01/2018
1	HeterochromatinIBA 01/2018
1	trichostatin A (A 300)IBA 01/2018

Therapy/Procedure

18	Therapeutics 10/2022 - 01/2002
16	Drug Therapy (Chemotherapy) 12/2021 - 01/2002
12	Radiotherapy 01/2021 - 04/2003
4	Immunotherapy 08/2021 - 01/2018
2	Aftercare (After-Treatment) 09/2021 - 10/2002
2	Prostatectomy (Retropubic Prostatectomy) 10/2008 - 06/2008
1	Precision Medicine 01/2020